Table of Contents Author Guidelines Submit a Manuscript
Journal of Parasitology Research
Volume 2012, Article ID 394981, 10 pages
http://dx.doi.org/10.1155/2012/394981
Research Article

Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection

1Serviço de Imunologia, Complexo Hospitalar Universitário Professor Edgard Santos, Universidade Federal da Bahia, Rua João das Botas s/n, Canela, 40.110-160 Salvador, BA, Brazil
2Departamento de Ciências da Vida, Universidade do Estado da Bahia, 2555 Rua Silveira Martins, Cabula, 41.150-000 Salvador, BA, Brazil
3Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT-CNPQ/MCT), Rua João das Botas s/n, Canela, 40.110-160 Salvador, BA, Brazil
4Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, UFBA, Avenida Adhemar de Barros s/n, Ondina, 40.170-970 Salvador, BA, Brazil
5Escola Bahiana de Medicina e Saúde Pública, Rua Frei Henrique No. 08, Nazaré, 40.050-420 Salvador, BA, Brazil

Received 13 July 2012; Accepted 7 November 2012

Academic Editor: Sergio Costa Oliveira

Copyright © 2012 Robson Da Paixão De Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Iarotski and A. Davis, “The schistosomiasis problem in the world: results of a WHO questionnaire survey,” Bulletin of the World Health Organization, vol. 59, no. 1, pp. 115–127, 1981. View at Google Scholar · View at Scopus
  2. Ministério da Saúde, Guia De Vigilância Epidemiológica, Ministério da Saúde, Brasília, Brasil, 2005.
  3. M. S. Wilson, M. M. Mentink-Kane, J. T. Pesce, T. R. Ramalingam, R. Thompson, and T. A. Wynn, “Immunopathology of schistosomiasis,” Immunology and Cell Biology, vol. 85, no. 2, pp. 148–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. A. Andrade, “Schistosomiasis and liver fibrosis: review Article,” Parasite Immunology, vol. 31, no. 11, pp. 656–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Bina, “Estudo de variáveis que podem influenciar na evolução da esquistossomose mansônica: efeito da terapêutica específica e da interrupção da transmissào,” Revista de Patologia Tropical, vol. 26, pp. 69–128, 1997. View at Google Scholar
  6. J. C. Bina and A. Prata, “Schistosomiasis in hyperendemic area of Taquarendi. I- Schistosoma mansoni infection and severe clinikal forms,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 36, no. 2, pp. 211–216, 2003. View at Google Scholar · View at Scopus
  7. S. Henri, C. Chevillard, A. Mergani et al., “Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease,” Journal of Immunology, vol. 169, no. 2, pp. 929–936, 2002. View at Google Scholar · View at Scopus
  8. P. L. Falcão, L. C. C. Malaquias, O. A. Martins-Filho et al., “Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation,” Parasite Immunology, vol. 20, no. 10, pp. 447–454, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gustavson, C. S. Zouain, J. B. Alves, M. F. Leite, and A. M. Goes, “Modulation of granulomatous hypersensitivity against Schistosoma mansoni eggs in mice vaccinated with culture-derived macrophages loaded with PIII,” Parasitology International, vol. 51, no. 3, pp. 259–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Wynn, “Cytokine regulation of granuloma formation in schistosomiasis,” Current Opinion in Immunology, vol. 7, no. 4, pp. 505–511, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Steinman, “A brief history of TH17, the first major revision in the T H1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. I. Rutitzky, L. Bazzone, M. G. Shainheit, B. Joyce-Shaikh, D. J. Cua, and M. J. Stadecker, “IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17,” Journal of Immunology, vol. 180, no. 4, pp. 2486–2495, 2008. View at Google Scholar · View at Scopus
  13. L. I. Rutitzky, J. R. L. Da Rosa, and M. J. Stadecker, “Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17,” Journal of Immunology, vol. 175, no. 6, pp. 3920–3926, 2005. View at Google Scholar · View at Scopus
  14. L. I. Rutitzky and M. J. Stadecker, “CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis,” Memorias do Instituto Oswaldo Cruz, vol. 101, no. 1, pp. 327–330, 2006. View at Google Scholar · View at Scopus
  15. N. Katz, P. M. Coelho, and J. Pellegrino, “Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces,” Journal of Parasitology, vol. 56, no. 5, pp. 1032–1033, 1970. View at Google Scholar · View at Scopus
  16. M. I. A. S. Araujo, B. Hoppe, M. Medeiros et al., “Impaired T helper 2 response to aeroallergen in helminth-infected patiente with asthma,” Journal of Infectious Diseases, vol. 190, no. 10, pp. 1797–1803, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Dessein, M. Begley, C. Demeure et al., “Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen,” Journal of Immunology, vol. 140, no. 8, pp. 2727–2736, 1988. View at Google Scholar · View at Scopus
  18. A. V. Grant, M. I. Araujo, E. V. Ponte et al., “High heritability but uncertain mode of inheritance for total serum IgE level and Schistosoma mansoni infection intensity in a schistosomiasis-endemic Brazilian population,” Journal of Infectious Diseases, vol. 198, no. 8, pp. 1227–1236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. F. Abdel-Wahab, G. Esmat, A. Farrag, Y. A. El-Boraey, and G. T. Strickland, “Grading of hepatic schistosomiasis by the use of ultrasonography,” American Journal of Tropical Medicine and Hygiene, vol. 46, no. 4, pp. 403–408, 1992. View at Google Scholar · View at Scopus
  20. A. R. De Jesus, A. Silva, L. B. Santana et al., “Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni,” Journal of Infectious Diseases, vol. 185, no. 1, pp. 98–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. De Jesus, D. G. Miranda, R. G. Miranda et al., “Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura,” American Journal of Tropical Medicine and Hygiene, vol. 63, no. 1-2, pp. 1–4, 2000. View at Google Scholar · View at Scopus
  22. L. F. A. Oliveira, E. C. Moreno, G. Gazzinelli et al., “Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans,” Infection and Immunity, vol. 74, no. 2, pp. 1215–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. E. J. Pearce, S. L. James, and J. Dalton, “Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine,” Journal of Immunology, vol. 137, no. 11, pp. 3593–3600, 1986. View at Google Scholar · View at Scopus
  24. C. Hirsch and A. M. Goes, “Characterization of fractionated Schistosoma mansoni soluble adult worm antigens that elicit human cell proliferation and granuloma formation in vitro,” Parasitology, vol. 112, no. 6, pp. 529–535, 1996. View at Google Scholar · View at Scopus
  25. M. Booth, J. K. Mwatha, S. Joseph et al., “Periportal Fibrosis in Human Schistosoma mansoni Infection Is Associated with Low IL-10, Low IFN-γ, High TNF-α, or Low RANTES, Depending on Age and Gender,” Journal of Immunology, vol. 172, no. 2, pp. 1295–1303, 2004. View at Google Scholar · View at Scopus
  26. Q. Mohamed-Ali, N. E. M. A. Elwali, A. A. Abdelhameed et al., “Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression,” Journal of Infectious Diseases, vol. 180, no. 4, pp. 1298–1306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Abdel-Wahab, G. Esmat, S. I. Narooz, A. Yosery, J. P. Struewing, and G. T. Strickland, “Sonographic studies of schoolchildren in a village endemic for Schistosoma mansoni,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 1, pp. 69–73, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Doehring-Schwerdtfeger, I. M. Abdel-Rahim, Q. Mohamed-Ali et al., “Ultrasonographical investigation of peripheral fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity,” American Journal of Tropical Medicine and Hygiene, vol. 42, no. 6, pp. 581–586, 1990. View at Google Scholar · View at Scopus
  29. A. L. C. Domingues, A. R. F. Lima, H. S. Dias, G. C. Leao, and A. Coutinho, “An ultrasonographic study of liver fibrosis in patients infected with Schistosoma mansoni in north-east Brazil,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 5, pp. 555–558, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Homeida, A. F. Abdel-Gadir, A. W. Cheever et al., “Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study,” American Journal of Tropical Medicine and Hygiene, vol. 38, no. 1, pp. 86–91, 1988. View at Google Scholar · View at Scopus
  31. A. J. Dessein, D. Hillaire, N. E. M. A. Elwali et al., “Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-γ receptor gene,” American Journal of Human Genetics, vol. 65, no. 3, pp. 709–721, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. O. S. Carvalho, P. M. Z. Coelho, and H. L. Lenzi, Schistosoma mansoni e Esquistossomose: Uma Visão Multidisciplinar, Editora Fiocruz, Rio de Janeiro, Brazil, 1st edition, 2008.
  33. M. G. Chiaramonte, A. W. Cheever, J. D. Malley, D. D. Donaldson, and T. A. Wynn, “Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis,” Hepatology, vol. 34, no. 2, pp. 273–282, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Chiaramonte, D. D. Donaldson, A. W. Cheever, and T. A. Wynn, “An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response,” Journal of Clinical Investigation, vol. 104, no. 6, pp. 777–785, 1999. View at Google Scholar · View at Scopus
  35. A. R. De Jesus, I. Araújo, O. Bacellar et al., “Human immune responses to Schistosoma mansoni vaccine candidate antigens,” Infection and Immunity, vol. 68, no. 5, pp. 2797–2803, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. A. R. De Jesus, A. Magalhães, D. G. Miranda et al., “Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection,” Infection and Immunity, vol. 72, no. 6, pp. 3391–3397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Magalhães, D. G. Miranda, R. G. Miranda et al., “Cytokine profile associated with human chronic schistosomiasis mansoni,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 5, supplement 1, pp. 21–26, 2004. View at Google Scholar · View at Scopus
  38. R. M. Reiman, R. W. Thompson, C. G. Feng et al., “Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity,” Infection and Immunity, vol. 74, no. 3, pp. 1471–1479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. D. N. Silva-Teixeira, C. Contigli, J. R. Lambertucci, J. C. Serufo, and V. Rodrigues, “Gender-related cytokine patterns in sera of schistosomiasis patients with symmers' fibrosis,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 627–630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. C. N. L. De Morais, J. R. De Souza, W. G. De Melo et al., “Studies on the production and regulation of interleukin, IL-13, IL-4 and interferon-γ in human schistosomiasis mansoni,” Memorias do Instituto Oswaldo Cruz, vol. 97, supplement 1, pp. 113–114, 2002. View at Google Scholar · View at Scopus
  41. M. I. Araújo, A. R. De Jesus, O. Bacellar, E. Sabin, E. Pearce, and E. M. Carvalho, “Evidence of a T helper type 2 activation in human schistosomiasis,” European Journal of Immunology, vol. 26, no. 6, pp. 1399–1403, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Tallima, M. Salah, F. R. Guirguis, and R. El Ridi, “Transforming growth factor-β and Th17 responses in resistance to primary murine schistosomiasis mansoni,” Cytokine, vol. 48, no. 3, pp. 239–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. L. C. Borish and J. W. Steinke, “2. Cytokines and chemokines,” Journal of Allergy and Clinical Immunology, vol. 111, no. 2, supplement, pp. S460–S475, 2003. View at Google Scholar · View at Scopus
  44. K. F. Hoffmann, P. Caspar, A. W. Cheever, and T. A. Wynn, “IFN-γ, IL-12, and TNF-α are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12,” Journal of Immunology, vol. 161, no. 8, pp. 4201–4210, 1998. View at Google Scholar · View at Scopus
  45. S. A. Shahat, M. A. El-Dhshan, S. S. Aissa, A. Dorra, and K. M. Metwally, “Flowcytometric analysis of T-lymphocytes and serum tumour necrosis factor alpha (TNF-alpha) levels in Schistosoma mansoni patients,” Journal of the Egyptian Society of Parasitology, vol. 37, no. 3, pp. 1065–1074, 2007. View at Google Scholar · View at Scopus
  46. M. O. Li, Y. Y. Wan, S. Sanjabi, A. K. L. Robertson, and R. A. Flavell, “Transforming growth factor-β regulation of immune responses,” Annual Review of Immunology, vol. 24, pp. 99–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Massague, J. Andres, L. Attisano et al., “TGF-β receptors,” Molecular Reproduction and Development, vol. 32, no. 2, pp. 99–104, 1992. View at Publisher · View at Google Scholar · View at Scopus
  48. R. R. El-Gamal, S. M. Nada, N. E. Moustafa et al., “Relationship between serum cytokines profiles and hepatic fibrosis in schistosomiasis mansoni: an experimental study,” Journal of the Egyptian Society of Parasitology, vol. 39, no. 3, pp. 907–916, 2009. View at Google Scholar · View at Scopus
  49. M. L. Burke, M. K. Jones, G. N. Gobert, Y. S. Li, M. K. Ellis, and D. P. McManus, “Immunopathogenesis of human schistosomiasis,” Parasite Immunology, vol. 31, no. 4, pp. 163–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. L. S. Souza, E. Roffê, V. Pinho et al., “Potential role of the chemokine macrophage inflammatory protein 1α in human and experimental schistosomiasis,” Infection and Immunity, vol. 73, no. 4, pp. 2515–2523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. P. R. S. Souza, A. L. S. Souza, D. Negrão-Correa, A. L. Teixeira, and M. M. Teixeira, “The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection,” Acta Tropica, vol. 108, no. 2-3, pp. 135–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. P. L. Falcão, R. Correa-Oliveira, L. A. O. Fraga et al., “Plasma concentrations and role of macrophage inflammatory protein-1α during chronic Schistosoma mansoni infection in humans,” Journal of Infectious Diseases, vol. 186, no. 11, pp. 1696–1700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. D. M. Oliveira, D. N. Silva-Teixeira, S. Gustavson, S. M. P. Oliveira, and A. M. Goes, “Nitric oxide interaction with IL-10, MIP-1α, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis,” Parasitology, vol. 120, no. 4, pp. 391–398, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Berkman, V. L. Krishnan, T. Gilbey et al., “Expression of RANTES mRNA and protein in airways of patients with mild asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 6, pp. 1804–1811, 1996. View at Google Scholar · View at Scopus
  55. M. John, S. J. Hirst, P. J. Jose et al., “Human Airway smooth muscle cells express and release RANTES in response to T helper 1 Cytokines: regulation by T helper 2 cytokines and corticosteroids,” Journal of Immunology, vol. 158, no. 4, pp. 1841–1847, 1997. View at Google Scholar · View at Scopus
  56. A. Marfaing-Koka, O. Devergne, G. Gorgone et al., “Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13,” Journal of Immunology, vol. 154, no. 4, pp. 1870–1878, 1995. View at Google Scholar · View at Scopus
  57. S. W. Chensue, K. S. Warmington, E. J. Allenspach et al., “Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation,” Journal of Immunology, vol. 163, no. 1, pp. 165–173, 1999. View at Google Scholar · View at Scopus